Tower Research Capital (TRC)’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-83
Closed -$1K 6658
2022
Q2
$1K Buy
83
+77
+1,283% +$760 ﹤0.01% 5912
2022
Q1
$0 Hold
6
﹤0.01% 6751
2021
Q4
$0 Buy
+6
New +$59 ﹤0.01% 6725

Other funds holding PEPL

Tower Research Capital (TRC)'s PEPL Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q3 2022, closing a stake of 83 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in PEPL in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 43 funds tracked by Wall St. Rank hold PEPL as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 83 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q3 2022, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $1K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.